A citation-based method for searching scientific literature


List of co-cited articles
78 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
Jérôme Solassol, Julie Vendrell, Bruno Märkl, Christian Haas, Beatriz Bellosillo, Clara Montagut, Matthew Smith, Brendan O'Sullivan, Nicky D'Haene, Marie Le Mercier,[...]. PLoS One 2016
31
48

BRAF mutation testing with a rapid, fully integrated molecular diagnostics system.
Filip Janku, Bart Claes, Helen J Huang, Gerald S Falchook, Benoit Devogelaere, Mark Kockx, Isabelle Vanden Bempt, Martin Reijans, Aung Naing, Siqing Fu,[...]. Oncotarget 2015
38
48

Clinical performance evaluation of the Idylla NRAS-BRAF mutation test on retrospectively collected formalin-fixed paraffin-embedded colorectal cancer tissue.
Louise Johnston, Michael Power, Philip Sloan, Anna Long, Angela Silmon, Ben Chaffey, Andrea Jane Lisgo, Liam Little, Ellen Vercauteren, Torben Steiniche,[...]. J Clin Pathol 2018
19
63

Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples.
Christine Weyn, Sofie Van Raemdonck, Robina Dendooven, Vincent Maes, Karen Zwaenepoel, Suzan Lambin, Patrick Pauwels. BMC Cancer 2017
16
68

Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma.
Linea Melchior, Morten Grauslund, Beatriz Bellosillo, Clara Montagut, Erica Torres, Ester Moragón, Isabel Micalessi, Johan Frans, Veerle Noten, Claire Bourgain,[...]. Exp Mol Pathol 2015
35
40


Multicenter Evaluation of a Novel Automated Rapid Detection System of BRAF Status in Formalin-Fixed, Paraffin-Embedded Tissues.
Ana-Iris Schiefer, Laura Parlow, Lisa Gabler, Ildiko Mesteri, Oskar Koperek, Andreas von Deimling, Berthold Streubel, Matthias Preusser, Annika Lehmann, Udo Kellner,[...]. J Mol Diagn 2016
25
32


Evaluation of a fast and fully automated platform to diagnose EGFR and KRAS mutations in formalin-fixed and paraffin-embedded non-small cell lung cancer samples in less than one day.
Laetitia Lambros, Charline Caumont, Briac Guibourg, Fanny Barel, Isabelle Quintin-Roué, Pascale Marcorelles, Jean-Philippe Merlio, Arnaud Uguen. J Clin Pathol 2017
32
28

Evaluation of a Rapid, Fully Automated Platform for Detection of BRAF and NRAS Mutations in Melanoma.
Fanny Barel, Briac Guibourg, Laetitia Lambros, Glen Le Flahec, Pascale Marcorelles, Arnaud Uguen. Acta Derm Venereol 2018
14
50

Financial implications of Idylla testing in colorectal cancer, lung cancer and melanoma: a French laboratory point of view.
Glen Le Flahec, Briac Guibourg, Pascale Marcorelles, Arnaud Uguen. J Clin Pathol 2017
8
87

Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates.
Dario de Biase, Caterina de Luca, Gianluca Gragnano, Michela Visani, Claudio Bellevicine, Umberto Malapelle, Giovanni Tallini, Giancarlo Troncone. J Clin Pathol 2016
26
24

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
E Van Cutsem, A Cervantes, R Adam, A Sobrero, J H Van Krieken, D Aderka, E Aranda Aguilar, A Bardelli, A Benson, G Bodoky,[...]. Ann Oncol 2016
24


Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform.
Cornelis Bisschop, Arja Ter Elst, Lisette J Bosman, Inge Platteel, Mathilde Jalving, Anke van den Berg, Arjan Diepstra, Bettien van Hemel, Gilles F H Diercks, Geke A P Hospers,[...]. Melanoma Res 2018
31
24

Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer.
Iván Prieto-Potin, Clara Montagut, Beatriz Bellosillo, Matthew Evans, Matthew Smith, Linea Melchior, Werner Reiltin, Michael Bennett, Veronica Pennati, Francesca Castiglione,[...]. J Mol Diagn 2018
19
31

EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay.
Caterina De Luca, Gianluca Gragnano, Pasquale Pisapia, Elena Vigliar, Umberto Malapelle, Claudio Bellevicine, Giancarlo Troncone. J Clin Pathol 2017
40
20

KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test.
Caterina De Luca, Elena Vigliar, Melania d'Anna, Pasquale Pisapia, Claudio Bellevicine, Umberto Malapelle, Giancarlo Troncone. Cytojournal 2017
9
55

BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System.
Filip Janku, Helen J Huang, Bart Claes, Gerald S Falchook, Siqing Fu, David Hong, Nishma M Ramzanali, Giovanni Nitti, Goran Cabrilo, Apostolia M Tsimberidou,[...]. Mol Cancer Ther 2016
61
20

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer.
Marius Ilie, Catherine Butori, Sandra Lassalle, Simon Heeke, Nicolas Piton, Jean-Christophe Sabourin, Virginie Tanga, Kevin Washetine, Elodie Long-Mira, Priscilla Maitre,[...]. Oncotarget 2017
38
20


NCCN Guidelines Insights: Melanoma, Version 3.2016.
Daniel G Coit, John A Thompson, Alain Algazi, Robert Andtbacka, Christopher K Bichakjian, William E Carson, Gregory A Daniels, Dominick DiMaio, Ryan C Fields, Martin D Fleming,[...]. J Natl Compr Canc Netw 2016
64
16

Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy.
Teofila Seremet, Simon Planken, Max Schreuer, Yanina Jansen, Mélanie Delaunoy, Hakim El Housni, Danielle Lienard, Véronique Del Marmol, Pierre Heimann, Bart Neyns. Melanoma Res 2018
15
26

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
Al B Benson, Alan P Venook, Lynette Cederquist, Emily Chan, Yi-Jen Chen, Harry S Cooper, Dustin Deming, Paul F Engstrom, Peter C Enzinger, Alessandro Fichera,[...]. J Natl Compr Canc Netw 2017
492
16

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology.
Antonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, Wayne Grody, Allison M Cushman-Vokoun, William K Funkhouser, Scott E Kopetz, Christopher Lieu, Noralane M Lindor, Bruce D Minsky,[...]. J Clin Oncol 2017
191
16

Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers.
Pawel Sadlecki, Pawel Walentowicz, Magdalena Bodnar, Andrzej Marszalek, Marek Grabiec, Malgorzata Walentowicz-Sadlecka. Tumour Biol 2017
11
27

EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.
Vincent Thomas De Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, Antoinette Lemoine, Benjamin Besse, Olaf Mercier, Élie Fadel, Peter Dorfmuller, Thierry Le Chevalier. Pathol Res Pract 2017
15
20

Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.
M Peeters, G Kafatos, A Taylor, V M Gastanaga, K S Oliner, G Hechmati, J-H Terwey, J H van Krieken. Eur J Cancer 2015
99
12

Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.
Caterina De Luca, Alessandra G Rappa, Gianluca Gragnano, Umberto Malapelle, Giancarlo Troncone, Massimo Barberis. J Clin Pathol 2018
25
12

Accelerated BRAF mutation analysis using a fully automated PCR platform improves the management of patients with metastatic melanoma.
Delphine Serre, Julia Salleron, Marie Husson, Agnès Leroux, Pauline Gilson, Jean-Louis Merlin, Lionnel Geoffrois, Alexandre Harlé. Oncotarget 2018
3
100

Evaluation, Validation, and Implementation of the Idylla System as Rapid Molecular Testing for Precision Medicine.
Huiya Huang, Stephanie Springborn, Kiefer Haug, Kaitlyn Bartow, Hasan Samra, Smitha Menon, Alexander C Mackinnon. J Mol Diagn 2019
19
15

Rapid clinical mutational testing of KRAS, BRAF and EGFR: a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing.
Matthias Van Haele, Sara Vander Borght, An Ceulemans, Michiel Wieërs, Sofie Metsu, Xavier Sagaert, Birgit Weynand. J Clin Pathol 2020
23
13

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer.
J Y Douillard, S Siena, J Cassidy, J Tabernero, R Burkes, M Barugel, Y Humblet, G Bodoky, D Cunningham, J Jassem,[...]. Ann Oncol 2014
331
8

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.
Jean-Yves Douillard, Salvatore Siena, James Cassidy, Josep Tabernero, Ronald Burkes, Mario Barugel, Yves Humblet, György Bodoky, David Cunningham, Jacek Jassem,[...]. J Clin Oncol 2010
8

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.
Christos S Karapetis, Shirin Khambata-Ford, Derek J Jonker, Chris J O'Callaghan, Dongsheng Tu, Niall C Tebbutt, R John Simes, Haji Chalchal, Jeremy D Shapiro, Sonia Robitaille,[...]. N Engl J Med 2008
8

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.
Rafael G Amado, Michael Wolf, Marc Peeters, Eric Van Cutsem, Salvatore Siena, Daniel J Freeman, Todd Juan, Robert Sikorski, Sid Suggs, Robert Radinsky,[...]. J Clin Oncol 2008
8

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.
Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre, Jerzy Zaluski, Chung-Rong Chang Chien, Anatoly Makhson, Geert D'Haens, Tamás Pintér, Robert Lim, György Bodoky,[...]. N Engl J Med 2009
8


RAS signaling pathways, mutations and their role in colorectal cancer.
Kypros Zenonos, Katy Kyprianou. World J Gastrointest Oncol 2013
75
8

Tumor cellularity as a quality assurance measure for accurate clinical detection of BRAF mutations in melanoma.
Jonathan C Dudley, Grzegorz T Gurda, Li-Hui Tseng, Derek A Anderson, Guoli Chen, Janis M Taube, Christopher D Gocke, James R Eshleman, Ming-Tseh Lin. Mol Diagn Ther 2014
27
8

MNAzymes, a versatile new class of nucleic acid enzymes that can function as biosensors and molecular switches.
Elisa Mokany, Simon M Bone, Paul E Young, Tram B Doan, Alison V Todd. J Am Chem Soc 2010
139
8

Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations.
Gregory J Tsongalis, Jason D Peterson, Francine B de Abreu, Christopher D Tunkey, Torrey L Gallagher, Linda D Strausbaugh, Wendy A Wells, Christopher I Amos. Clin Chem Lab Med 2014
109
8


Colorectal cancer statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Stacey A Fedewa, Dennis J Ahnen, Reinier G S Meester, Afsaneh Barzi, Ahmedin Jemal. CA Cancer J Clin 2017
8

Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
8

Detection of KRAS G12D in colorectal cancer stool by droplet digital PCR.
Susana Olmedillas-López, Dennis César Lévano-Linares, Carmen Laura Aúz Alexandre, Luz Vega-Clemente, Edurne León Sánchez, Alejandro Villagrasa, Jaime Ruíz-Tovar, Mariano García-Arranz, Damián García-Olmo. World J Gastroenterol 2017
8
25

Integrating liquid biopsies into the management of cancer.
Giulia Siravegna, Silvia Marsoni, Salvatore Siena, Alberto Bardelli. Nat Rev Clin Oncol 2017
968
8

BRAF V600E mutation in hairy cell leukemia: from bench to bedside.
Brunangelo Falini, Maria Paola Martelli, Enrico Tiacci. Blood 2016
52
8

Fully automated real-time PCR for EGFR testing in non-small cell lung carcinoma.
Richard Colling, Hollie Bancroft, Gerald Langman, Elizabeth Soilleux. Virchows Arch 2019
19
10

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.